IP Verse

Kraus & Lederer Partgmbb patent opposition analysis

The comprehensive analysis of Kraus & Lederer Partgmbb opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Kraus & Lederer Partgmbb

Stay updated with the latest patent oppositions filed by Kraus & Lederer Partgmbb

Patent NumberTitleApplicantOpposition DateOpposition Company
EP4209493
Solid Forms And Formulations Of (S)-4-(8-Amino-3-(1-(But-2-Ynoyl)Pyrrolidin-2-Yl)Imidazo[1,5-A]Pyrazin-1-Yl)-N-(Pyridin-2-Yl)BenzamideACERTA PHARMA B.V.Aug 11, 2026KRAUS & LEDERER PARTGMBB
EP3836920
Formulations Of Ag10EIDOS THERAPEUTICS, INC.Jun 30, 2026SANDOZ
EP3903594
Fat Composition Used For ChocolateWILMAR (SHANGHAI) BIOTECHNOLOGY RESEARCH & DEVELOPMENT CENTER CO., LTD.Jun 9, 2026KRAUS & LEDERER PARTGMBB
EP4406594
Method Of Synthesizing Thyroid Hormone Analogs And Polymorphs ThereofMADRIGAL PHARMACEUTICALS, INC.Jun 9, 2026SANDOZ
EP3432729
Nanocapsules Comprising A Liposoluble Active Ingredient, Production And UsesADISSEO FRANCE S.A.S.May 12, 2026DSM NUTRITIONAL PRODUCTS
EP3689365
Use Of Long-Acting Glp-1 PeptidesNOVO NORDISK A/SMar 24, 2026KRAUS & LEDERER PARTGMBB
EP4316598
Pharmaceutical Composition Containing Poorly-Soluble Basic MedicineCHUGAI SEIYAKU KABUSHIKI KAISHAMar 18, 2026TEVA PHARMACEUTICAL INDUSTRIES LTD
EP4370650
Method For Isolating Proteins And Saccharides From YeastYEASTUP AGJan 15, 2026KRAUS & LEDERER PARTGMBB
EP3592732
Manufacture Of A Crystalline Pharmaceutical ProductORION CORPORATIONJan 8, 2026KRAUS & LEDERER PARTGMBB
EP3256113
Treatment Of HypoparathyroidismENTERA BIO LTD.Dec 29, 2025KRAUS & LEDERER PARTGMBB

Top clients of Kraus & Lederer Partgmbb

Top companies who are the clients of Kraus & Lederer Partgmbb

CompanyTotal
KRAUS & LEDERER PARTGMBB71
SANDOZ28
TEVA PHARMACEUTICAL INDUSTRIES LTD25
DSM NUTRITIONAL PRODUCTS15
HEXAL5
STADA ARZNEIMITTEL4
DSM ASSETS4
ALFASIGMA4
RHODIA OPERATIONS3
LUYE PHARMA SWITZERLAND2